Cite
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
MLA
Goodman, Phyllis J., et al. “Opportunities and Challenges in Incorporating Ancillary Studies into a Cancer Prevention Randomized Clinical Trial.” Trials, vol. 17, Aug. 2016, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13063-016-1524-9.
APA
Goodman, P. J., Tangen, C. M., Darke, A. K., Arnold, K. B., Hartline, J., Yee, M., Anderson, K., Caban-Holt, A., Christen, W. G., Cassano, P. A., Lance, P., Klein, E. A., Crowley, J. J., Minasian, L. M., & Meyskens, F. L. (2016). Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial. Trials, 17, 1–10. https://doi.org/10.1186/s13063-016-1524-9
Chicago
Goodman, Phyllis J., Catherine M. Tangen, Amy K. Darke, Kathryn B. Arnold, JoAnn Hartline, Monica Yee, Karen Anderson, et al. 2016. “Opportunities and Challenges in Incorporating Ancillary Studies into a Cancer Prevention Randomized Clinical Trial.” Trials 17 (August): 1–10. doi:10.1186/s13063-016-1524-9.